Epsilon M&A Deal Report - DOC Generici
Transaction Multiples for the Valuation of Private Companies
Private Group led by Charterhouse Capital Partners LLP / DOC Generici
No EMAT :
62906
Announced Date :
22/05/2013
Type :
LBO (Leverage Buy Out)
Deal Value :
Yes
Acquirer :
Private Group led by Charterhouse Capital Partners LLP
Target :
DOC Generici
Country :
Italy
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Founded in 1996, DOC GENERICI is the third-largest generics player in the Italian market . It engages in the production and distribution of equivalent medicines/generic drugs in Italy . It is...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
||
| Current |
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
| Date | Acquirer | Target | Country | Multiples | See details |
| 17/01/2014 | Aurobindo Pharma | Actavis Generics Commercial Operations In Euro Zone Markets | France | ** | 62880 |
| 19/05/2011 | STADA Arzneimittel | Spirig Healthcare | Switzerland | ** | 62850 |
Source: Epsilon Research / EMAT
